Your browser doesn't support javascript.
loading
Building a Healthcare Alliance for Resourceful Medicine Offensive Against Neoplasms in Hematology Added Value Framework for Hematologic Malignancies: A Comparative Analysis of Existing Tools.
Cerisoli, Francesco; Ali, Farzad; Bereczky, Tamás; Bolaños, Natacha; Bullinger, Lars; Dhanasiri, Sujith; Gallagher, James; Pérez, Sonia García; Geissler, Jan; Guillevic, Yann; Harrison, Kathryn; Naoum, Anastasia; Portulano, Carla; Rodríguez Vicente, Ana E; Schulze-Rath, Renate; Gómez, Gabriela Yumi; Sanz, Guillermo; Hernández Rivas, Jesús María.
Afiliação
  • Cerisoli F; European Hematology Association, The Hague, The Netherlands.
  • Ali F; Patient Health Impact, Pfizer, Montreal, Quebec, Canada.
  • Bereczky T; Patvocates GmbH, Munich, Bayern, Germany.
  • Bolaños N; Regional Management Europe, Lymphoma Coalition, Madrid, Spain.
  • Bullinger L; Charité - Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt, Berlin, Germany.
  • Dhanasiri S; Global Medical Affairs, Celgene International - A Bristol Myers Squibb Company, Boudry, Switzerland.
  • Gallagher J; Pfizer Inc, New York, NY, USA.
  • Pérez SG; Department of Medicines for Human Use, Spanish Agency of Medicines and Medical Devices (AEMPS), Madrid, Spain.
  • Geissler J; Patvocates GmbH, Munich, Bayern, Germany.
  • Guillevic Y; Global Medical Affairs, Celgene International - A Bristol Myers Squibb Company, Boudry, Switzerland.
  • Harrison K; Science Policy and Research Programme, National Institute for Health and Care Excellence (NICE), Manchester, England, UK.
  • Naoum A; European Hematology Association, The Hague, The Netherlands.
  • Portulano C; Menarini Ricerche SpA, Florence, Italy.
  • Rodríguez Vicente AE; Departamento de Medicina, Universidad de Salamanca, Salamanca, Spain.
  • Schulze-Rath R; Medical Affairs & Pharmacovigilance, Pharmaceuticals, Bayer AG, Berlin, Germany.
  • Gómez GY; Agencia Española de Medicamentos y Productos Sanitarios (AEMPS), Madrid, Spain.
  • Sanz G; CIBERONC, Instituto de Salud Carlos III, Madrid, Spain; Hospital Universitari i Politècnic la Fe, Valencia, Spain.
  • Hernández Rivas JM; Servicio de Hematología, Instituto de Investigación Biomédica de Salamanca (IBSAL), Departamento de Medicina, Hospital Universitario de Salamanca, Universidad de Salamanca, Salamanca, Spain. Electronic address: jmhr@usal.es.
Value Health ; 25(10): 1760-1767, 2022 10.
Article em En | MEDLINE | ID: mdl-35595634
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Hematológicas / Hematologia / Neoplasias Tipo de estudo: Clinical_trials / Health_technology_assessment / Qualitative_research Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Hematológicas / Hematologia / Neoplasias Tipo de estudo: Clinical_trials / Health_technology_assessment / Qualitative_research Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article